Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma
- Resource Type
- Journal
- Source
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL ; DEC 2012, 97 12, p1925-p1928, 4p.- Subject
- Language
- English
- ISSN
- 03906078